1). Notably, the beneficial alloreactive T cells responsible for GvL are the same T cells that mediate GvHD. However, despite the fact that GvL and GvHD are driven by the same cells, they manifest ...

Graft-versus-host disease (GvHD) is a complication of a bone marrow or stem cell transplant in which cells from a donor ...

Gastrointestinal (GI) problems, liver dysfunction, skin rashes, and other symptoms can develop as acute (temporary) GVHD within 100 days of a transplant or as chronic GVHD months — or even years ...

Steroid therapy is the first-line treatment for graft-versus-host disease (GVHD). If GVHD does not respond to initial therapies, doctors may consider chemotherapy, monoclonal antibodies ...

The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...

The regulator has cleared Ryoncil (remestemcel-L) to treat steroid-refractory acute GVHD in paediatric patients aged two months and older. It is derived from MSCs harvested from the bone marrow of ...

Considering taking supplements to treat graft versus host disease gvhd? Below is a list of common natural remedies used to treat or reduce the symptoms of graft versus host disease gvhd.

Expert Rev Hematol. 2008;1(1):111-128. Currently, none of these agents have displaced corticosteroids as upfront therapy for acute GVHD, but there is significant interest in finding better ...